InvestorsObserver
×
News Home

Should Biotechnology Stock Mustang Bio Inc (MBIO) Be in Your Portfolio Wednesday?

Wednesday, May 31, 2023 12:22 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Mustang Bio Inc (MBIO) Be in Your Portfolio Wednesday?

Mustang Bio Inc (MBIO) is near the top in its industry group according to InvestorsObserver. MBIO gets an overall rating of 69. That means it scores higher than 69 percent of stocks. Mustang Bio Inc gets a 78 rank in the Biotechnology industry. Biotechnology is number 18 out of 148 industries.

Overall Score - 69
MBIO has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on MBIO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 69 would rank higher than 69 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Mustang Bio Inc Stock Today?

Mustang Bio Inc (MBIO) stock has gained 3.06% while the S&P 500 has fallen -0.76% as of 12:06 PM on Wednesday, May 31. MBIO is up $0.19 from the previous closing price of $6.21 on volume of 50,153 shares. Over the past year the S&P 500 is higher by 1.00% while MBIO has fallen -33.88%. MBIO lost -$10.29 per share the over the last 12 months. Click Here to get the full Stock Report for Mustang Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App